PDL BioPharma, Inc. (NASDAQ:PDLI)
CAPS Rating:
A biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for severe or life-threatening illnesses.
A biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for severe or life-threatening illnesses.
Recs
Magic formula pick, shows up on multiple mechanical stock screens with proven returns over 20 plus years. Undervalued.